Form 4: Vivani Medical Director Receives Stock Options

Vivani Medical, Inc. reports that Director August J. Moretti was granted 36,000 non-qualified stock options with an exercise price of $1.22.

Summary

• August J. Moretti, a Director at Vivani Medical, Inc., received a grant of 36,000 non-qualified stock options.
• The options have an exercise price of $1.22 per share.
• The grant was made on June 24, 2026, and is part of the Issuer's Non-Employee Director Compensation Policy.
• These options vest in monthly installments over a three-year period, contingent upon continued service.
• The underlying securities are 36,000 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details a standard director compensation event without immediate financial impact or significant strategic shifts.

Positives

• Director compensation aligns with company stock ownership, potentially incentivizing long-term performance.
• The grant is structured with a vesting schedule, encouraging continued service and commitment from the director.

Negatives

• The exercise price of $1.22 is above the current market price, suggesting the options may not provide immediate value unless the stock price appreciates significantly.

Risks

• The value of the stock options is directly tied to the future performance and stock price of Vivani Medical, Inc., which carries inherent market risks.
• Vesting is contingent on continued service, meaning the director could forfeit unvested options if they leave the company before the vesting period is complete.

Future Outlook

The future outlook for the stock options is dependent on Vivani Medical, Inc.'s stock price performance over the next three years, as the options vest monthly and expire in 2036.

Management Comments

• The option grant is awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
• The option vests in monthly installments over the three-year period following the grant date, subject to continued service through such date.

Industry Context

StockSavvy.ai notes that granting stock options to directors is a common practice in the biotechnology and medical device sectors to align executive interests with shareholder value and attract/retain talent.

Corporate Governance

Related Party Transactions

• The grant of stock options to Director August J. Moretti is a related party transaction, governed by the Non-Employee Director Compensation Policy.

Stakeholder Impact

• Shareholders: The grant aligns director incentives with shareholder interests, potentially leading to decisions that enhance stock value. Dilution is minimal given the nature of option grants.
• Employees: This filing does not directly impact employees but reflects standard compensation practices for non-employee directors.
• Management: The filing confirms a standard compensation practice for directors.

Next Steps

• August J. Moretti will continue to serve as a Director, subject to the vesting schedule of the stock options.
• The company will continue to operate under its Non-Employee Director Compensation Policy for future grants.

Key Dates

Keywords

Vivani Medical, VANI, Form 4, Stock Options, Director Compensation, SEC Filing, Equity Grant, Beneficial Ownership